JolantaMalyszko PolandMedical University of Warsaw, Poland

JolantaMalyszko
I am board certified specialist in internal medicine, nephrology, clinical transplantation, hypertension and diabetology. In 1995 I received Ph.D. at Hamamatsu University School of Medicine, Japan. Head of Department of Nephrology, Dialysis and Internal Medicine, Warsaw Medical University from December 2018. My clinical training was performed in France, Germany, UK, Israel. Member of EDRA-EDTA Executive Council (2015-2018). Member of the Executive Council of KDIGO (2019-2022). Member of Ceartal Eastern Europe -Vice Chair, ISN (2023-2025). My major research interest are: hypertension, cardiovascular complications in CKD, iron metabolism and anemia, onconephrology, AKI. I am author and co-author of over 800 original papers in peer-reviewed journals, (IF~1600, citations >9000 and h-index-50).
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/d134cec909bc5de513af8a27b1661f74.jpg
First Name
Jolanta
Last Name
Malyszko
Institution
Country.
Poland

Friday, February 7, 2025

Time Session
9:45 a.m.
11:15 a.m.
IK01
GeorgiAbraham Chair IndiaMGM Healthcare, Chennai, India
KriangTungsanga Chair ThailandDepartment of Medicine, Faculty of Medicine, Chulalongkorn Unviersity
SanjayD'Cruz Chair IndiaGovernment Medical College & Hospital, Chandigarh
  • Renal Complications of Novel Cancer Therapies: Practical Insights
    IK01-01
    AnushreeShirali Speaker United StatesYale University
  • Immune Checkpoint Inhibitors and AKI
    IK01-02
    MitchellRosner Speaker United StatesUniveristy of Virginia Health
  • Electrolyte Abnormalities in the Cancer Patient
    IK01-03
    JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland
  • Opening an Onconephrology Clinic - What Should You Be Aware of?
    IK01-04
    KenarJhaveri Speaker United StatesNorthwell Health
  • Q&A
    IK01-05
Amaltas Hall B101-A

Saturday, February 8, 2025

Time Session
2:15 p.m.
3:45 p.m.
SK05
JolantaMalyszko Chair PolandMedical University of Warsaw, Poland
ValentineLobo Chair IndiaNephrology Unit, King Edward Memorial Hospital, Pune
  • Deciphering the Molecular Development of Kidney Disease: Transition From AKI to CKD
    SK05-01
    SanjayJain Speaker United StatesWashington University School of Medicine
  • KidGen Consortium - Integrating Genomic Medicine Into Care
    SK05-02
    AndrewMallett Speaker AustraliaJCU & THHS
  • Metadata Ontology, Knowledge Integration, and Kidney Precision Medicine
    SK05-03
    MatthiasKretzler Speaker United StatesUniversity of Michigan
  • Kidney Health Professionals and AI - Pioneers or Passive Users?
    SK05-04
    GirishNadkarni Speaker United StatesIcahn School of Medicine at Mount Sinai and the Mount Sinai Health System
  • Q&A
    SK05-05
Amaltas Hall B101-A

Thursday, February 6, 2025

Time Session
9 a.m.
11 a.m.
NAR1
KenarJhaveri Chair United StatesNorthwell Health
MitchellRosner Chair United StatesUniveristy of Virginia Health
  • New Solutions to Anemia Management in Kidney Failure: The Role of HIF-PH Inhibitors
    NAR1-01
    JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland
  • New Solutions to Phosphorus Control in Kidney Failure: Achieving Patient Goals
    NAR1-02
    KrishnaswamySampathkumar Speaker IndiaMeenakshi Mission Hospital
  • Improving Volume and Hypertension Control in Kidney Failure: New Approaches to a Critical Issue?
    NAR1-03
    Angela Yee-MoonWang Speaker SingaporeHong Kong/Singapore
  • Q and A
    NAR1-04
Neelkamal Hall 305